PuSH - Publikationsserver des Helmholtz Zentrums München

Trambauer, J.* ; Rodríguez Sarmiento, R.M.* ; Fukumori, A.* ; Feederle, R. ; Baumann, K.* ; Steiner, H.*

A beta 43-producing PS1 FAD mutants cause altered substrate interactions and respond to gamma-secretase modulation.

EMBO Rep. 21:e47996 (2020)
Verlagsversion Forschungsdaten DOI
Open Access Gold (Paid Option)
Creative Commons Lizenzvertrag
Abnormal generation of neurotoxic amyloid-beta peptide (A beta) 42/43 species due to mutations in the catalytic presenilin 1 (PS1) subunit of gamma-secretase is the major cause of familial Alzheimer's disease (FAD). Deeper mechanistic insight on the generation of A beta 43 is still lacking, and it is unclear whether gamma-secretase modulators (GSMs) can reduce the levels of this A beta species. By comparing several types of A beta 43-generating FAD mutants, we observe that very high levels of A beta 43 are often produced when presenilin function is severely impaired. Altered interactions of C99, the precursor of A beta, are found for all mutants and are independent of their particular effect on A beta production. Furthermore, unlike previously described GSMs, the novel compound RO7019009 can effectively lower A beta 43 production of all mutants. Finally, substrate-binding competition experiments suggest that RO7019009 acts mechanistically after initial C99 binding. We conclude that altered C99 interactions are a common feature of diverse types of PS1 FAD mutants and that also patients with A beta 43-generating FAD mutations could in principle be treated by GSMs.
Altmetric
Weitere Metriken?
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter A Beta 43 ; Amyloid Beta-peptide ; Familial Alzheimer's Disease ; Presenilin ; Gamma-secretase Modulator; Amyloid Precursor Protein; Disease-associated Presenilin-1; Familial Alzheimer-disease; A-beta; Cleavage Specificity; Gxgd-motif; In-vivo; Mutations; App; Generation
ISSN (print) / ISBN 1469-221X
e-ISSN 1469-3178
Zeitschrift EMBO Reports
Quellenangaben Band: 21, Heft: 1, Seiten: , Artikelnummer: e47996 Supplement: ,
Verlag EMBO Press
Verlagsort 111 River St, Hoboken 07030-5774, Nj Usa
Begutachtungsstatus
Institut(e) Monoclonal Antibody (MAB)